The global Urine Based Glucose Monitoring market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Urine-based glucose monitoring is a method used to measure glucose levels in urine samples. While not as accurate as blood-based monitoring, urine testing can provide an indication of glucose levels and help in diabetes management.
The market for urine-based glucose monitoring is driven by factors such as its simplicity and cost-effectiveness, making it a viable option in certain healthcare settings or resource-limited environments. However, the growing popularity of blood-based and non-invasive glucose monitoring methods may impact the market's growth in the long term.
This report includes an overview of the development of the Urine Based Glucose Monitoring industry chain, the market status of Hospitals (Wearable Blood Glucose Monitoring Systems, Table Top Blood Glucose Monitoring Systems), Clinics (Wearable Blood Glucose Monitoring Systems, Table Top Blood Glucose Monitoring Systems), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Urine Based Glucose Monitoring.
Regionally, the report analyzes the Urine Based Glucose Monitoring markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Urine Based Glucose Monitoring market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Urine Based Glucose Monitoring market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Urine Based Glucose Monitoring industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Wearable Blood Glucose Monitoring Systems, Table Top Blood Glucose Monitoring Systems).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Urine Based Glucose Monitoring market.
Regional Analysis: The report involves examining the Urine Based Glucose Monitoring market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Urine Based Glucose Monitoring market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Urine Based Glucose Monitoring:
Company Analysis: Report covers individual Urine Based Glucose Monitoring manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Urine Based Glucose Monitoring This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Urine Based Glucose Monitoring. It assesses the current state, advancements, and potential future developments in Urine Based Glucose Monitoring areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Urine Based Glucose Monitoring market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Urine Based Glucose Monitoring market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Wearable Blood Glucose Monitoring Systems
Table Top Blood Glucose Monitoring Systems
Market segment by Application
Hospitals
Clinics
Others
Major players covered
Abbott
Medtronic
Roche
Bayer AG
B. Braun
Nipro Diagnostics
Life Scan Inc.(J&J)
Arkray Devices
Nova Biomedical
Bionime Corporation
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Urine Based Glucose Monitoring product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Urine Based Glucose Monitoring, with price, sales, revenue and global market share of Urine Based Glucose Monitoring from 2019 to 2024.
Chapter 3, the Urine Based Glucose Monitoring competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Urine Based Glucose Monitoring breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Urine Based Glucose Monitoring market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Urine Based Glucose Monitoring.
Chapter 14 and 15, to describe Urine Based Glucose Monitoring sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Urine Based Glucose Monitoring
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Urine Based Glucose Monitoring Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Wearable Blood Glucose Monitoring Systems
1.3.3 Table Top Blood Glucose Monitoring Systems
1.4 Market Analysis by Application
1.4.1 Overview: Global Urine Based Glucose Monitoring Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Global Urine Based Glucose Monitoring Market Size & Forecast
1.5.1 Global Urine Based Glucose Monitoring Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Urine Based Glucose Monitoring Sales Quantity (2019-2030)
1.5.3 Global Urine Based Glucose Monitoring Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Urine Based Glucose Monitoring Product and Services
2.1.4 Abbott Urine Based Glucose Monitoring Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Abbott Recent Developments/Updates
2.2 Medtronic
2.2.1 Medtronic Details
2.2.2 Medtronic Major Business
2.2.3 Medtronic Urine Based Glucose Monitoring Product and Services
2.2.4 Medtronic Urine Based Glucose Monitoring Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Medtronic Recent Developments/Updates
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Urine Based Glucose Monitoring Product and Services
2.3.4 Roche Urine Based Glucose Monitoring Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Roche Recent Developments/Updates
2.4 Bayer AG
2.4.1 Bayer AG Details
2.4.2 Bayer AG Major Business
2.4.3 Bayer AG Urine Based Glucose Monitoring Product and Services
2.4.4 Bayer AG Urine Based Glucose Monitoring Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Bayer AG Recent Developments/Updates
2.5 B. Braun
2.5.1 B. Braun Details
2.5.2 B. Braun Major Business
2.5.3 B. Braun Urine Based Glucose Monitoring Product and Services
2.5.4 B. Braun Urine Based Glucose Monitoring Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 B. Braun Recent Developments/Updates
2.6 Nipro Diagnostics
2.6.1 Nipro Diagnostics Details
2.6.2 Nipro Diagnostics Major Business
2.6.3 Nipro Diagnostics Urine Based Glucose Monitoring Product and Services
2.6.4 Nipro Diagnostics Urine Based Glucose Monitoring Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Nipro Diagnostics Recent Developments/Updates
2.7 Life Scan Inc.(J&J)
2.7.1 Life Scan Inc.(J&J) Details
2.7.2 Life Scan Inc.(J&J) Major Business
2.7.3 Life Scan Inc.(J&J) Urine Based Glucose Monitoring Product and Services
2.7.4 Life Scan Inc.(J&J) Urine Based Glucose Monitoring Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Life Scan Inc.(J&J) Recent Developments/Updates
2.8 Arkray Devices
2.8.1 Arkray Devices Details
2.8.2 Arkray Devices Major Business
2.8.3 Arkray Devices Urine Based Glucose Monitoring Product and Services
2.8.4 Arkray Devices Urine Based Glucose Monitoring Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Arkray Devices Recent Developments/Updates
2.9 Nova Biomedical
2.9.1 Nova Biomedical Details
2.9.2 Nova Biomedical Major Business
2.9.3 Nova Biomedical Urine Based Glucose Monitoring Product and Services
2.9.4 Nova Biomedical Urine Based Glucose Monitoring Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Nova Biomedical Recent Developments/Updates
2.10 Bionime Corporation
2.10.1 Bionime Corporation Details
2.10.2 Bionime Corporation Major Business
2.10.3 Bionime Corporation Urine Based Glucose Monitoring Product and Services
2.10.4 Bionime Corporation Urine Based Glucose Monitoring Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Bionime Corporation Recent Developments/Updates
3 Competitive Environment: Urine Based Glucose Monitoring by Manufacturer
3.1 Global Urine Based Glucose Monitoring Sales Quantity by Manufacturer (2019-2024)
3.2 Global Urine Based Glucose Monitoring Revenue by Manufacturer (2019-2024)
3.3 Global Urine Based Glucose Monitoring Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Urine Based Glucose Monitoring by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Urine Based Glucose Monitoring Manufacturer Market Share in 2023
3.4.2 Top 6 Urine Based Glucose Monitoring Manufacturer Market Share in 2023
3.5 Urine Based Glucose Monitoring Market: Overall Company Footprint Analysis
3.5.1 Urine Based Glucose Monitoring Market: Region Footprint
3.5.2 Urine Based Glucose Monitoring Market: Company Product Type Footprint
3.5.3 Urine Based Glucose Monitoring Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Urine Based Glucose Monitoring Market Size by Region
4.1.1 Global Urine Based Glucose Monitoring Sales Quantity by Region (2019-2030)
4.1.2 Global Urine Based Glucose Monitoring Consumption Value by Region (2019-2030)
4.1.3 Global Urine Based Glucose Monitoring Average Price by Region (2019-2030)
4.2 North America Urine Based Glucose Monitoring Consumption Value (2019-2030)
4.3 Europe Urine Based Glucose Monitoring Consumption Value (2019-2030)
4.4 Asia-Pacific Urine Based Glucose Monitoring Consumption Value (2019-2030)
4.5 South America Urine Based Glucose Monitoring Consumption Value (2019-2030)
4.6 Middle East and Africa Urine Based Glucose Monitoring Consumption Value (2019-2030)
5 Market Segment by Type
5.1 Global Urine Based Glucose Monitoring Sales Quantity by Type (2019-2030)
5.2 Global Urine Based Glucose Monitoring Consumption Value by Type (2019-2030)
5.3 Global Urine Based Glucose Monitoring Average Price by Type (2019-2030)
6 Market Segment by Application
6.1 Global Urine Based Glucose Monitoring Sales Quantity by Application (2019-2030)
6.2 Global Urine Based Glucose Monitoring Consumption Value by Application (2019-2030)
6.3 Global Urine Based Glucose Monitoring Average Price by Application (2019-2030)
7 North America
7.1 North America Urine Based Glucose Monitoring Sales Quantity by Type (2019-2030)
7.2 North America Urine Based Glucose Monitoring Sales Quantity by Application (2019-2030)
7.3 North America Urine Based Glucose Monitoring Market Size by Country
7.3.1 North America Urine Based Glucose Monitoring Sales Quantity by Country (2019-2030)
7.3.2 North America Urine Based Glucose Monitoring Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
8.1 Europe Urine Based Glucose Monitoring Sales Quantity by Type (2019-2030)
8.2 Europe Urine Based Glucose Monitoring Sales Quantity by Application (2019-2030)
8.3 Europe Urine Based Glucose Monitoring Market Size by Country
8.3.1 Europe Urine Based Glucose Monitoring Sales Quantity by Country (2019-2030)
8.3.2 Europe Urine Based Glucose Monitoring Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Urine Based Glucose Monitoring Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Urine Based Glucose Monitoring Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Urine Based Glucose Monitoring Market Size by Region
9.3.1 Asia-Pacific Urine Based Glucose Monitoring Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Urine Based Glucose Monitoring Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
10.1 South America Urine Based Glucose Monitoring Sales Quantity by Type (2019-2030)
10.2 South America Urine Based Glucose Monitoring Sales Quantity by Application (2019-2030)
10.3 South America Urine Based Glucose Monitoring Market Size by Country
10.3.1 South America Urine Based Glucose Monitoring Sales Quantity by Country (2019-2030)
10.3.2 South America Urine Based Glucose Monitoring Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Urine Based Glucose Monitoring Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Urine Based Glucose Monitoring Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Urine Based Glucose Monitoring Market Size by Country
11.3.1 Middle East & Africa Urine Based Glucose Monitoring Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Urine Based Glucose Monitoring Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
12.1 Urine Based Glucose Monitoring Market Drivers
12.2 Urine Based Glucose Monitoring Market Restraints
12.3 Urine Based Glucose Monitoring Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Urine Based Glucose Monitoring and Key Manufacturers
13.2 Manufacturing Costs Percentage of Urine Based Glucose Monitoring
13.3 Urine Based Glucose Monitoring Production Process
13.4 Urine Based Glucose Monitoring Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Urine Based Glucose Monitoring Typical Distributors
14.3 Urine Based Glucose Monitoring Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Abbott
Medtronic
Roche
Bayer AG
B. Braun
Nipro Diagnostics
Life Scan Inc.(J&J)
Arkray Devices
Nova Biomedical
Bionime Corporation
听
听
*If Applicable.
